You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
京新藥業(002020.SZ):目前沒有與鹽野義製藥、輝瑞製藥展開新冠藥物方面的相關合作

格隆匯3月27日丨京新藥業(002020.SZ)發佈股價異動公吿,近日,公司注意到網絡上存在有關“公司有三氟苯甲酰氯新冠藥的原料藥”京新藥業兩市同時擁有鹽野義/輝瑞新冠藥關鍵中間體的唯一一家標的”傳聞。公司在此澄清:公司原料藥主要為喹諾酮類他汀類精神神經類藥物目前公司及子公司沒有與鹽野義製藥、輝瑞製藥展開新冠藥物方面的相關合作公司山東基地規劃的 2,4,5-三氟酰氯製備 2,4,5-三氟苄的關鍵中間體投產尚需要一定週期,預計對公司2022業績無實質性影響,對公司未來後續年度業績的影響存在較大不確定性公司將持續密切關注新冠治療藥物在國內外的進展情況,根據市場需求變化,謹慎做出決策敬請各位投資者關注投資風險,理性投資。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account